CIBC WORLD MARKET INC. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIBC WORLD MARKET INC. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$646,000
+12.9%
4,130
+16.3%
0.00%
+50.0%
Q1 2018$572,000
-21.6%
3,550
-19.9%
0.00%
-33.3%
Q4 2017$730,0004,4300.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 99,306$14,027,0005.76%
Casdin Capital, LLC 312,000$44,070,0005.36%
Palo Alto Investors LP 840,372$118,703,0004.80%
BB BIOTECH AG 1,071,373$151,331,0004.00%
TRV GP II, LLC 37,362$5,277,0003.10%
Eversept Partners, LP 43,621$6,161,4662.70%
RA Capital Management 350,933$49,569,0002.65%
Eventide Asset Management 494,000$69,778,0002.56%
OAK RIDGE INVESTMENTS LLC 241,099$34,055,0001.88%
SUFFOLK CAPITAL MANAGEMENT LLC 93,000$13,136,0001.87%
View complete list of SAGE THERAPEUTICS INC shareholders